囊性纤维化的肝脏表现。
Hepatic Manifestations of Cystic Fibrosis.
机构信息
Division of Gastroenterology and Hepatology, University of Maryland School of Medicine, University of Maryland Medical Center, 22 South Greene Street, N3W50, Baltimore, MD 21201, USA.
Laboratory of Pathology, National Cancer Institute, National Institutes of Health, 10 Center Drive, Building 10, Room 2S235, MSC 1500, Bethesda, MD 20892, USA.
出版信息
Clin Liver Dis. 2019 May;23(2):263-277. doi: 10.1016/j.cld.2018.12.008. Epub 2019 Feb 21.
Abstract
Cystic fibrosis liver disease (CFLD) remains the third leading cause of death in patients with cystic fibrosis. Although most patients with CFLD present in childhood, recent studies suggest a second wave of liver disease in adulthood. There are no clear guidelines for diagnosing CFLD. Treatment options for CFLD remain limited, and while UDCA is widely used, its long-term benefit is unclear. Those who develop hepatic decompensation or uncontrolled variceal bleeding may benefit from liver transplant, either alone, or in combination with lung transplant.
摘要
囊性纤维化肝病（CFLD）仍然是囊性纤维化患者的第三大死亡原因。尽管大多数 CFLD 患者在儿童期出现，但最近的研究表明，成年人中也存在第二波肝病。目前尚无明确的 CFLD 诊断指南。CFLD 的治疗选择仍然有限，UDCA 虽然被广泛应用，但长期疗效尚不清楚。那些出现肝功能失代偿或无法控制的静脉曲张出血的患者可能受益于单独或与肺移植联合进行肝移植。
相似文献
1
Hepatic Manifestations of Cystic Fibrosis.囊性纤维化的肝脏表现。
Clin Liver Dis. 2019 May;23(2):263-277. doi: 10.1016/j.cld.2018.12.008. Epub 2019 Feb 21.
2
Diagnosis, follow-up and treatment of cystic fibrosis-related liver disease.囊性纤维化相关肝病的诊断、随访及治疗
Curr Opin Pulm Med. 2017 Nov;23(6):562-569. doi: 10.1097/MCP.0000000000000428.
3
Long-term prospective study of the effect of ursodeoxycholic acid on cystic fibrosis-related liver disease.熊去氧胆酸对囊性纤维化相关肝病影响的长期前瞻性研究。
J Clin Gastroenterol. 2001 Apr;32(4):324-8. doi: 10.1097/00004836-200104000-00009.
4
[Hepatobiliary disease in cystic fibrosis].[囊性纤维化中的肝胆疾病]
Med Clin (Barc). 1998 Sep 19;111(8):302-6.
5
Cystic fibrosis-associated liver disease.囊性纤维化相关性肝病。
Best Pract Res Clin Gastroenterol. 2010 Oct;24(5):585-92. doi: 10.1016/j.bpg.2010.08.003.
6
The benign course of liver disease in adults with cystic fibrosis and the effect of ursodeoxycholic acid.成年囊性纤维化患者肝病的良性病程及熊去氧胆酸的作用
Liver Int. 2007 Dec;27(10):1402-8. doi: 10.1111/j.1478-3231.2007.01570.x.
7
The natural history of cystic fibrosis liver disease a prospective cohort study.囊性纤维化肝病的自然史：一项前瞻性队列研究。
J Cyst Fibros. 2023 Nov;22(6):1054-1061. doi: 10.1016/j.jcf.2023.07.002. Epub 2023 Jul 24.
8
Current Treatment Options for Cystic Fibrosis-Related Liver Disease.囊性纤维化相关性肝病的治疗选择。
Int J Mol Sci. 2020 Nov 14;21(22):8586. doi: 10.3390/ijms21228586.
9
Endogenous ursodeoxycholic acid and cholic acid in liver disease due to cystic fibrosis.囊性纤维化所致肝病中的内源性熊去氧胆酸和胆酸
Hepatology. 2004 Jun;39(6):1673-82. doi: 10.1002/hep.20238.
10
A Multidisciplinary Approach to Pretransplant and Posttransplant Management of Cystic Fibrosis-Associated Liver Disease.多学科方法在囊性纤维化相关肝病的移植前和移植后的管理。
Liver Transpl. 2019 Apr;25(4):640-657. doi: 10.1002/lt.25421. Epub 2019 Mar 20.
引用本文的文献
1
Sotagliflozin attenuates liver-associated disorders in cystic fibrosis rabbits.索他格列净可减轻囊性纤维化兔的肝脏相关疾病。
JCI Insight. 2024 Feb 15;9(6):e165826. doi: 10.1172/jci.insight.165826.
2
Liver magnetic resonance elastography and fat fraction in pediatric patients with cystic fibrosis versus healthy children.肝磁共振弹性成像和脂肪分数在囊性纤维化患儿与健康儿童中的比较。
Pediatr Radiol. 2024 Feb;54(2):250-259. doi: 10.1007/s00247-023-05832-1. Epub 2023 Dec 22.
3
Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations.囊性纤维化肝胆道疾病筛查、评估和管理的共识建议。
Hepatology. 2024 May 1;79(5):1220-1238. doi: 10.1097/HEP.0000000000000646. Epub 2023 Oct 26.
4
Cystic fibrosis rabbits develop spontaneous hepatobiliary lesions and CF-associated liver disease (CFLD)-like phenotypes.囊性纤维化兔会出现自发性肝胆病变以及类似囊性纤维化相关肝病（CFLD）的表型。
PNAS Nexus. 2022 Dec 23;2(1):pgac306. doi: 10.1093/pnasnexus/pgac306. eCollection 2023 Jan.
5
Fatty liver disease that is neither metabolic nor alcoholic.非代谢性或酒精性脂肪性肝病。
Hum Pathol. 2023 Nov;141:212-221. doi: 10.1016/j.humpath.2023.01.003. Epub 2023 Jan 24.
6
Bisphosphonates for osteoporosis in people with cystic fibrosis.用于囊性纤维化患者骨质疏松症的双膦酸盐。
Cochrane Database Syst Rev. 2023 Jan 10;1(1):CD002010. doi: 10.1002/14651858.CD002010.pub5.
7
- dual-modal magnetic resonance contrast-enhanced imaging for rat liver fibrosis stage.用于大鼠肝纤维化分期的双模态磁共振对比增强成像
RSC Adv. 2022 Dec 14;12(55):35809-35819. doi: 10.1039/d2ra05913d. eCollection 2022 Dec 12.
8
The microbiota and the gut-liver axis in primary sclerosing cholangitis.原发性硬化性胆管炎中的微生物群与肠-肝轴
Nat Rev Gastroenterol Hepatol. 2023 Mar;20(3):135-154. doi: 10.1038/s41575-022-00690-y. Epub 2022 Nov 9.
9
Bile Acids-A Peek Into Their History and Signaling.胆汁酸——探索它们的历史和信号通路。
Endocrinology. 2022 Oct 11;163(11). doi: 10.1210/endocr/bqac155.
10
Cystic fibrosis liver disease in Newfoundland and Labrador: a prevalence study.纽芬兰与拉布拉多省的囊性纤维化肝病：一项患病率研究。
Can Liver J. 2021 Feb 24;4(1):33-37. doi: 10.3138/canlivj-2020-0012. eCollection 2021 Winter.
本文引用的文献
1
Surgical management of noncirrhotic portal hypertension.非肝硬化性门静脉高压症的外科治疗
Clin Liver Dis (Hoboken). 2015 May 27;5(5):112-115. doi: 10.1002/cld.470. eCollection 2015 May.
2
Liver Disease in Cystic Fibrosis: Illuminating the Black Box.囊性纤维化中的肝脏疾病：揭开黑箱之谜。
Hepatology. 2019 Apr;69(4):1379-1381. doi: 10.1002/hep.30255. Epub 2019 Feb 14.
3
Cystic Fibrosis Liver Disease: Outcomes and Risk Factors in a Large Cohort of French Patients.囊性纤维化肝病：法国大样本队列患者的结局和风险因素。
Hepatology. 2019 Apr;69(4):1648-1656. doi: 10.1002/hep.30148. Epub 2018 Dec 28.
4
The Efficacy of MRI in the diagnostic workup of cystic fibrosis-associated liver disease: A clinical observational cohort study.MRI 在囊性纤维化相关性肝病诊断中的作用：一项临床观察队列研究。
Eur Radiol. 2019 Feb;29(2):1048-1058. doi: 10.1007/s00330-018-5650-5. Epub 2018 Jul 27.
5
Assessment of liver disease in cystic fibrosis.囊性纤维化中的肝病评估。
Paediatr Respir Rev. 2018 Jun;27:24-27. doi: 10.1016/j.prrv.2018.05.010. Epub 2018 May 18.
6
Primary sclerosing cholangitis is associated with abnormalities in CFTR.原发性硬化性胆管炎与 CFTR 的异常有关。
J Cyst Fibros. 2018 Sep;17(5):666-671. doi: 10.1016/j.jcf.2018.04.005. Epub 2018 May 26.
7
Practical approach to the gastrointestinal manifestations of cystic fibrosis.囊性纤维化胃肠道表现的实用处理方法
J Paediatr Child Health. 2018 Jun;54(6):609-619. doi: 10.1111/jpc.13921. Epub 2018 May 16.
8
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases.肝细胞癌的诊断、分期及管理：美国肝病研究协会2018年实践指南
Hepatology. 2018 Aug;68(2):723-750. doi: 10.1002/hep.29913.
9
Liver disease in patients with cystic fibrosis.囊性纤维化患者的肝脏疾病
Curr Opin Gastroenterol. 2018 May;34(3):146-151. doi: 10.1097/MOG.0000000000000432.
10
Assessment of Liver Disease Progression in Cystic Fibrosis Using Transient Elastography.使用瞬时弹性成像评估囊性纤维化患者的肝脏疾病进展情况。
J Pediatr Gastroenterol Nutr. 2018 Mar;66(3):455-460. doi: 10.1097/MPG.0000000000001822.
Zotero 插件